Muna Therapeutics Email Format

Biotechnology ResearchHovedstaden, Denmark51-200 Employees

Muna Therapeutics is a privately held biotechnology company founded in 2020 and based in Copenhagen, Denmark. It concentrates on discovering and developing therapies aimed at slowing or stopping neurodegenerative diseases, including Alzheimer’s, Frontotemporal Dementia and Parkinson’s, with the goal of preserving cognitive function and brain resilience.

As a mid-sized player in the biotechnology research space, the company works to advance new medicines that address memory and other brain functions affected by neurodegeneration. In 2024, Muna announced a research alliance with GlaxoSmithKline to identify and validate novel drug targets for Alzheimer's disease. The organization operates within the biotech and pharmaceutical development ecosystem, collaborating with partners to translate scientific findings into potential therapies.

Sign up for free to view info

Company overview Employee directory